Webinar

Pharmacy-Based Buprenorphine Initiation: An Evolving Care Model for Marginalized People

In this presentation, we will consider the need for expanded models of medications for opioid use disorder and how a pharmacy-based buprenorphine care approach could work.  The talk will overview findings of a recent study of pharmacy-based induction and maintenance therapy with buprenorphine in Rhode Island, and prospects for adopting this model for other substance […]

Pharmacy-Based Buprenorphine Initiation: An Evolving Care Model for Marginalized People Read More »

Sublingual Buprenorphine and the Oral Cavity | ME SUD Learning Community

Like many medications, Sublingual Buprenorphine has desirable therapeutic effects for patients, but undesirable side effects on patients’ mouths. This has been especially evident in recent months as a number of lawsuits have been filed, alleging that Sublingual Buprenorphine caused dental damage to patients. In this webinar, participants will review the basic elements of oral health, understand

Sublingual Buprenorphine and the Oral Cavity | ME SUD Learning Community Read More »

Bipolar and Alcohol Use Disorders: Not a Simple Coincidence

In the US, almost one of every two people with Bipolar Disorder suffer with comorbid Alcohol Use Disorder.  This complicates the diagnosis, the prognosis and the course of an already difficult to treat illness. We will review epidemiological data, some theories intended to explain this association, and the most evidence-based pharmacological and therapeutic interventions. Learning Objectives:

Bipolar and Alcohol Use Disorders: Not a Simple Coincidence Read More »

Inpatient Buprenorphine Treatment for Opioid Use Disorder

This review will briefly describe the underlying pathophysiology of opioid use disorder and medication used to treat withdrawal and cravings. The focus of the pharmacotherapy options will be the partial opioid agonist buprenorphine. The pharmacology and pharmacokinetics of buprenorphine will be discussed in depth as well as initiation strategies for diverse clinical scenarios. Learning Objectives:

Inpatient Buprenorphine Treatment for Opioid Use Disorder Read More »

Inpatient Buprenorphine Treatment for Opioid Use Disorder

This review will briefly describe the underlying pathophysiology of opioid use disorder and medication used to treat withdrawal and cravings. The focus of the pharmacotherapy options will be the partial opioid agonist buprenorphine. The pharmacology and pharmacokinetics of buprenorphine will be discussed in depth as well as initiation strategies for diverse clinical scenarios. Objectives: 1-describe

Inpatient Buprenorphine Treatment for Opioid Use Disorder Read More »

Recovery Coaching in Healthcare Settings – Mutual Support Space

Randy Morrison will lead a monthly space for peer supporters (recovery coaches, CIPSS) in Maine will offer mutual support to explore the challenges and opportunities of working within healthcare settings and to offer training. It will build a space for peer supporters to connect with each other, create a community of support, develop skills, and

Recovery Coaching in Healthcare Settings – Mutual Support Space Read More »

Recovery Coaching in Healthcare Settings – Mutual Support Space

Randy Morrison will lead a monthly space for peer supporters (recovery coaches, CIPSS) in Maine will offer mutual support to explore the challenges and opportunities of working within healthcare settings and to offer training. It will build a space for peer supporters to connect with each other, create a community of support, develop skills, and

Recovery Coaching in Healthcare Settings – Mutual Support Space Read More »